Helomics offers a select group of clinically relevant protein expression and genetic mutation tests associated with drug response and disease prognosis. Only well-validated tests are included in our biomarker menu with citations of supporting literature provided in every test report. Physicians can select biomarkers for testing from carefully chosen panels of relevant tests, intuitively organized by cancer pathway and tumor type. Results for these tests are presented in a clear, easy to understand format, including summaries of the clinical relevance of each marker. 

Questions, comments or concerns? Feel free to reach out to us at anytime.


A message about COVID-19

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon